Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Preclinical Efficacy of the Auristatin-Based Antibody-Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid Tumors.

Sommer A, Kopitz C, Schatz CA, Nising CF, Mahlert C, Lerchen HG, Stelte-Ludwig B, Hammer S, Greven S, Schuhmacher J, Braun M, Zierz R, Wittemer-Rump S, Harrenga A, Dittmer F, Reetz F, Apeler H, Jautelat R, Huynh H, Ziegelbauer K, Kreft B.

Cancer Res. 2016 Nov 1;76(21):6331-6339. Epub 2016 Aug 19.

2.

A new animal model of venous thrombosis in rats with low flow conditions in the venous blood stream.

Fredrich M, Zierz R, Morser J, Wydro R, Witt W.

Blood Coagul Fibrinolysis. 1994 Apr;5(2):243-8.

PMID:
8054457
3.

Elevated plasma levels of the immunosuppressive complement fragment Ba in renal failure.

Oppermann M, Kurts C, Zierz R, Quentin E, Weber MH, Götze O.

Kidney Int. 1991 Nov;40(5):939-47.

4.

The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1.

Montz H, Koch KC, Zierz R, Götze O.

Immunology. 1991 Nov;74(3):373-9.

5.

Determination of the epitope specificities of monoclonal antibodies using unprocessed supernatants of hybridoma cultures.

Würzner R, Oppermann M, Zierz R, Baumgarten H, Götze O.

J Immunol Methods. 1990 Feb 9;126(2):231-7.

PMID:
1689363
6.

Determination of the T3-3A1 antigen in PHA-induced human T-cells by standardized cell-ELISA.

Baumgarten H, Beulshausen H, Bätzing-Feigenbaum J, Bieber F, Zierz R, Götze O.

J Immunol Methods. 1987 Feb 11;96(2):201-9.

PMID:
3492562

Supplemental Content

Support Center